Research programme: diabetes therapy - Roche/Yissum
Latest Information Update: 29 Oct 2009
At a glance
- Originator Yissum Research Development Company
- Developer Roche; Yissum Research Development Company
- Class
- Mechanism of Action Cannabinoid receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Phase Unknown Type 1 diabetes mellitus; Type 2 diabetes mellitus
Most Recent Events
- 23 Oct 2009 Investigation in Type-1 diabetes mellitus in Israel (unspecified route)
- 23 Oct 2009 Investigation in Type-2 diabetes mellitus in Israel (unspecified route)